Pay in 4 interest-free payments of $37.50 Learn more
Ships within 48 hours · Estimated delivery Nov 2 - Nov 7
Rapamycin (Sirolimus
Dasatinib (BMS-354825) is a highly potent
Methods developed by different labs are tedious and unpractical
bafilomycin A1 has been shown to protect neurons from damage
Shown to ameliorate glycometabolism and insulin resistance through the upregulation of GLUT4
Adagrasib Lipid Raft Rapamycin (SirolimusAdagrasib (MRTX849) is a potent, orally available, and mutation selective covalent inhibitor of KRAS G12C with potential antineoplastic activity. Adagrasib covalently binds to KRAS G12C at the cysteine at residue 12, locks the protein in its inactive GDP bound conformation, and inhibits KRAS dependent signal transduction.
US$ 150.00
US$ 150.00
US$ 109.00
US$ 120.00